Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor Monotherapy vs DAPT in ACS (TICO)
NCT02494895Phase 4Unknown
- Sponsor
- Yonsei University
- Start
- Aug 2015
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ticagrelor in acute coronary syndrome (ACS) (2 arms), sponsored by Yonsei University. Primary endpoints: Major Adverse Cardiovascular Clinical Events at 1 year and Major Bleeding at 1 year. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02494895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02494895.